| Tag | Content |
|---|
EnhancerAtlas ID | HS170-02650 |
Organism | Homo sapiens |
Tissue/cell | RS4-11 |
Coordinate | chr3:40665010-40665750 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF4 | MA0039.3 | chr3:40665335-40665346 | CCACACCCTCT | + | 6.02 | | MEF2A | MA0052.3 | chr3:40665200-40665212 | GCTATAAATAGC | + | 6.32 | | MEF2B | MA0660.1 | chr3:40665200-40665212 | GCTATAAATAGC | + | 7.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10708 | chr3:40664352-40667985 | CD19_Primary | | SE_11768 | chr3:40663906-40668485 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I040623 | chr3 | 40664645 | 40667157 |
|
Enhancer Sequence | TGCTCAGTTG CCTGTTTGGT CCTTTCTCTC TTCTTGATCA CCCCTTTCCT CTCTGGCTCC 60
CACATATGGT TCAAAACCTG AACACACACA TTGGCCTGCT CCTCTTCTGG CTCACAAGAG 120
AAATGAATTG GCTGGCAGGA GACCAGTATC CACCTGATGA AGCAATAAAC CATGTGGCAT 180
GTAGATATTG GCTATAAATA GCTTCCCTTC ATTATCTCCT CACTCAAAGC CCTTGCCTTT 240
GAGTACCACG TCATCCCTTG GTGCTGACAC ACCCAAACCA AAGCCAGTCT CCCTAGCAAC 300
TGAACCACAG TCAGTGGTGG TCTGACCACA CCCTCTCATG GTTGGCAACC ATGCACAGTT 360
CCTCATTTTA TTTCTGCTGC AGGACAGGTT GGCTACTGGC TGATCTTTGG AACTAGAAAC 420
ATCATTTTGC TCCTTAAATG ATTAAAAAAG GCACACATGG GGCTTCTTTG TGTTAGTTCT 480
TTTGTATCTC CATATCCTGT CCCTGCATGG ATTATTTTGG TGCATGCTGC AGACTTGTTT 540
TTGGAACTTG AATCCTGAGC AAGTGAGAAG ACTTACTGGA TGCTGTTCAA GGCTCTGCAT 600
GACAAACCTT GCACAAATAC AAGGTATGAT TGCCACTGAC AGGGAGGATC ATGAGCTAGC 660
TGGGATGTAG GGAAAGATCA GGTGGCAAAG GTGTTTCAGG TGCAGGTGTA TCTTGCCCAG 720
GGTGCCCACC TCAGCAAGTG 740
|
